Breast Oncology - Dana-Farber Cancer Institute

Breast OncologyThe Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber provides comprehensive care for women with alltypes of breast cancer, including ductal carcinoma in situ, infiltrating (invasive) ductal carcinoma, lobular carcinoma in situ, infiltrating (invasive)lobular carcinoma, inflammatory breast cancer, Paget’s disease, and phylloides tumor. We offer specialized expertise for patients with metastaticbreast cancer or breast cancer during pregnancy, as well as an Inflammatory Breast Cancer Program, and the Program for Young Women with BreastCancer which addresses the unique needs of women under 40 who are diagnosed with breast cancer. Experts in the Cancer Genetics and PreventionProgram can also create a personalized plan for women at higher risk for developing breast or ovarian cancer.Patients receive care from a multidisciplinary team of health care professionals with extensive experience and expertise in the unique needs ofwomen with breast cancer. This includes medical, surgical, and radiation oncologists specializing in breast cancer, as well as radiologists,pathologists, reproductive medicine specialists, plastic surgeons, oncology nurses, genetic counselors, and more.Clinical research is a vital aspect of our mission at the Breast Oncology Program. We believe that outstanding clinical care is directly linked to anactive program of clinical research. Physician-researchers take the questions that arise from their experiences in the clinic, answer them throughclinical trials, and take this new knowledge back to the clinic, where it can benefit patients.At any given time, dozens of research studies involving hundreds of patients are under way within the Breast Oncology Program. These studies arebroad in scope: investigations of prevention and early-detection strategies, new therapies, novel combinations of existing treatments, quality-of-lifestudies, and laboratory analyses of tumor samples to better understand the relationship between tumor types and patient outcomes.Our team is also leading the way in treating breast cancer as a complex family of diseases rather than a single disease. All tumors are assessed formolecular markers that guide therapy and help determine eligibility for clinical trials exploring innovative new therapies.New Patient Appointment Phone: 617-632-2175Fax: 617-632-3715Leadership - Breast OncologyJ. Dirk Iglehart, MD, Director, Susan F. Smith Center for Women’s CancersEric P. Winer, MD, Director, Breast Oncology CenterMehra Golshan, MD, FACS, Director, Breast Surgical ServicesJay R. Harris, MD, Chair, Radiation OncologyTreatment TeamMedical OncologyCraig A. Bunnell, MD, MPH, MBAHarold J. Burstein, MD, PhDWendy Y. Chen, MD, MPHRachel A. Freedman, MD, MPHJudy E. Garber, MD, MPHMichael Hassett, MD, MPHRinath M. Jeselsohn, MDIan E. Krop, MD, PhDJennifer A. Ligibel, MDNancy U. Lin, MDErica L. Mayer, MD, MPHSusan E. Moody, MD, PhDDaniel Morganstern, MDBeth Overmoyer, MDLeroy M. Parker, MDAnn H. Partridge, MD, MPHRochelle G. Scheib, MDLawrence N. Shulman, MDDaniel P. Silver, MD, PhDSara M. Tolaney, MD, MPHNikhil Wagle, MDEric P. Winer, MDRachel L. Yung, MDPathologyJane E. Brock, MD, PhDDeborah A. Dillon, MDSusan C. Lester, MD, PhDAndrea L. Richardson, MD, PhDRadiation OncologyJennifer R. Bellon, MDJay R. Harris, MDSusan M. Pierce, MDRinaa S. Punglia, MD, MPHJulia S. Wong, MDResearcherMyles A. Brown, MDElgene Lim, MD, PhDSurgical OncologyThanh U. Barbie, MDKatharine Carter, MDLaura S. Dominici, MDMargaret M. Duggan, MD, FACSMehra Golshan, MD, FACSJ. Dirk Iglehart, MDFaina Nakhlis, MDEsther Rhei, MDSusan L. Troyan, MDTo make an appointment,call 877-332-4294www.dana-farber.org 4